A 22‐single nucleotide polymorphism Alzheimer's disease risk score correlates with family history, onset age, and cerebrospinal fluid Aβ 42-Reference-Cited by-同舟云学术

A 22‐single nucleotide polymorphism Alzheimer's disease risk score correlates with family history, onset age, and cerebrospinal fluid Aβ 42

Published:2015-06-15 Issue:12 Volume:11 Page:1452-1460
ISSN:1552-5260
Container-title:Alzheimer's & Dementia
language:en
Short-container-title:Alzheimer's & Dementia

Author:

Sleegers Kristel¹²,Bettens Karolien¹²,De Roeck Arne¹²,Van Cauwenberghe Caroline¹²,Cuyvers Elise¹²,Verheijen Jan¹²,Struyfs Hanne²,Van Dongen Jasper¹²,Vermeulen Steven¹²,Engelborghs Sebastiaan²³,Vandenbulcke Mathieu⁴,Vandenberghe Rik⁵,De Deyn Peter Paul²³⁶,Van Broeckhoven Christine¹²,

Affiliation:

1. Neurodegenerative Brain Diseases Group Department of Molecular Genetics VIB Antwerp Belgium

2. Institute Born‐Bunge, University of Antwerp Antwerp Belgium

3. Department of Neurology and Memory Clinic Hospital Network Antwerp Middelheim and Hoge Beuken Antwerp Belgium

4. Department of Old Age Psychiatry and Memory Clinic University of Leuven and University Hospitals Leuven Gasthuisberg Leuven Belgium

5. Laboratory for Cognitive Neurology Department of Neurology University of Leuven and University Hospitals Leuven Gasthuisberg Leuven Belgium

6. Department of Neurology Alzheimer Research Center University of Groningen, University Medical Center Groningen Groningen The Netherlands

Funder

Alzheimer's Disease Research Foundation

Departement Economie, Wetenschap en Innovatie

Fonds Wetenschappelijk Onderzoek

Research Foundation Flanders

Agency for Innovation by Science and Technology, Flanders

University of Antwerp Research Fund

Medical Research Foundation Antwerp

Innovative Medicines Initiative

Publisher

Wiley

Subject

Psychiatry and Mental health,Cellular and Molecular Neuroscience,Geriatrics and Gerontology,Clinical Neurology,Developmental Neuroscience,Health Policy,Epidemiology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1016/j.jalz.2015.02.013

Reference28 articles.

1. Forecasting the global burden of Alzheimer's disease

2. Biomarker Modeling of Alzheimer’s Disease

3. Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease

4. Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease

5. Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease

Cited by 95 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association of polygenic risk scores with Alzheimer's disease and plasma biomarkers among Chinese older adults: A community‐based study;Alzheimer's & Dementia;2024-08-22

2. Polygenic Risk Score Reveals Genetic Heterogeneity of Alzheimer’s Disease between the Chinese and European Populations;The Journal of Prevention of Alzheimer's Disease;2024

3. Alzheimer’s disease and clinical trials;Journal of Basic and Clinical Physiology and Pharmacology;2024-01-01

4. Polygenic risk scores for Alzheimer's disease in relation to cognitive change: A representative sample from the general population followed over 16 years.;Neurobiology of Disease;2023-12

5. Transferability of a European-derived Alzheimer’s Disease Genetic Risk Score across Multi-Ancestry Populations;2023-10-19